Lisa Nolan
2017
In 2017, Lisa Nolan earned a total compensation of $469K as Chief Business Officer at Rexahn Pharmaceuticals, a 17% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $79,625 |
|---|---|
| Option Awards | $36,391 |
| Salary | $325,000 |
| Stock Awards | $11,960 |
| Other | $16,027 |
| Total | $469,003 |
Nolan received $325K in salary, accounting for 69% of the total pay in 2017.
Nolan also received $79.6K in non-equity incentive plan, $36.4K in option awards, $12K in stock awards and $16K in other compensation.
Rankings
In 2017, Lisa Nolan's compensation ranked 12,077th out of 14,666 executives tracked by ExecPay. In other words, Nolan earned more than 17.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,077 out of 14,666 | 18th |
Division Manufacturing | 4,760 out of 5,772 | 18th |
Major group Chemicals And Allied Products | 1,738 out of 2,075 | 16th |
Industry group Drugs | 1,439 out of 1,731 | 17th |
Industry Pharmaceutical Preparations | 1,120 out of 1,333 | 16th |
Source: SEC filing on April 23, 2018.
Nolan's colleagues
We found three more compensation records of executives who worked with Lisa Nolan at Rexahn Pharmaceuticals in 2017.